亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation

医学 凝血病 弥漫性血管内凝血 败血症 重症监护医学 血栓形成 胞外囊泡 内科学 微泡 生物化学 基因 小RNA 化学
作者
Toshiaki Iba,Jerrold H. Levy,Aditya Raj,Theodore E. Warkentin
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:8 (5): 728-728 被引量:155
标识
DOI:10.3390/jcm8050728
摘要

Coagulopathy commonly occurs in sepsis as a critical host response to infection that can progress to disseminated intravascular coagulation (DIC) with an increased mortality. Recent studies have further defined factors responsible for the thromboinflammatory response and intravascular thrombosis, including neutrophil extracellular traps, extracellular vesicles, damage-associated molecular patterns, and endothelial glycocalyx shedding. Diagnosing DIC facilitates sepsis management, and is associated with improved outcomes. Although the International Society on Thrombosis and Haemostasis (ISTH) has proposed criteria for diagnosing overt DIC, these criteria are not suitable for early detection. Accordingly, the ISTH DIC Scientific Standardization Committee has proposed a new category termed "sepsis-induced coagulopathy (SIC)" to facilitate earlier diagnosis of DIC and potentially more rapid interventions in these critically ill patients. Therapy of SIC includes both treatment of the underlying infection and correcting the coagulopathy, with most therapeutic approaches focusing on anticoagulant therapy. Recently, a phase III trial of recombinant thrombomodulin was performed in coagulopathic patients. Although the 28-day mortality was improved by 2.6% (absolute difference), it did not reach statistical significance. However, in patients who met entry criteria for SIC at baseline, the mortality difference was approximately 5% without increased risk of bleeding. In this review, we discuss current advances in managing SIC and DIC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
搜集达人的应助被风吹麦浪采纳,获得10
刚刚
ding的应助被风吹麦浪采纳,获得10
刚刚
桐桐的应助被风吹麦浪采纳,获得10
刚刚
所所的应助被风吹麦浪采纳,获得10
刚刚
领导范儿的应助被风吹麦浪采纳,获得10
刚刚
NexusExplorer的应助被风吹麦浪采纳,获得10
1秒前
JamesPei的应助被风吹麦浪采纳,获得10
1秒前
Akim的应助被风吹麦浪采纳,获得10
1秒前
慕青的应助被风吹麦浪采纳,获得10
1秒前
研友_VZG7GZ的应助被风吹麦浪采纳,获得10
1秒前
顾矜的应助被风吹麦浪采纳,获得10
1秒前
上官若男的应助被风吹麦浪采纳,获得10
1秒前
酷波er的应助被风吹麦浪采纳,获得10
1秒前
h11的应助被风吹麦浪采纳,获得10
1秒前
大个的应助被风吹麦浪采纳,获得10
1秒前
嘻嘻哈哈的应助被风吹麦浪采纳,获得10
1秒前
科研通AI2S的应助被风吹麦浪采纳,获得10
2秒前
bkagyin的应助被风吹麦浪采纳,获得200
2秒前
共享精神的应助被风吹麦浪采纳,获得10
2秒前
李林鑫完成签到 ,获得积分10
2秒前
Orange的应助被风吹麦浪采纳,获得10
2秒前
大模型的应助被风吹麦浪采纳,获得10
2秒前
领导范儿的应助被风吹麦浪采纳,获得10
2秒前
搜集达人的应助被风吹麦浪采纳,获得10
2秒前
CodeCraft的应助被风吹麦浪采纳,获得10
2秒前
今后的应助被风吹麦浪采纳,获得10
2秒前
小二郎的应助被风吹麦浪采纳,获得10
2秒前
英俊的铭的应助被风吹麦浪采纳,获得10
2秒前
充电宝的应助被风吹麦浪采纳,获得10
3秒前
Ava的应助被风吹麦浪采纳,获得10
3秒前
h11的应助被风吹麦浪采纳,获得10
3秒前
嘻嘻哈哈的应助被风吹麦浪采纳,获得10
3秒前
orixero的应助被风吹麦浪采纳,获得10
3秒前
万能图书馆的应助被风吹麦浪采纳,获得10
3秒前
烟花的应助被风吹麦浪采纳,获得10
3秒前
小蘑菇的应助被风吹麦浪采纳,获得10
3秒前
xcp完成签到,获得积分10
4秒前
天地法相完成签到,获得积分10
5秒前
6秒前
Louuuue完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158533
求助须知:如何正确求助?哪些是违规求助? 9554315
关于积分的说明 21718840
捐赠科研通 7747967
什么是DOI,文献DOI怎么找? 3427015
关于科研通互助平台的介绍 2551811
邀请新用户注册赠送积分活动 2471239